Product nameAnti-Kallikrein 5 antibody - Kallikrein loop
See all Kallikrein 5 primary antibodies
DescriptionRabbit polyclonal to Kallikrein 5 - Kallikrein loop
SpecificityThis antibody reacts with Kallikrein 5, but does not react with the other Kallikreins (1-7 and 9-15).
Tested applicationsSuitable for: WB, ICC/IFmore details
Species reactivityReacts with: Human
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: 0.05% Sodium azide
Constituent: 50% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab28565 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 32 kDa. 1/1000 (when using colorimetric substrates such as BCIP/NBT)- 1/5000 (chemiluminescent substrates). Dilution optimised using Chromogenic detection.|
|ICC/IF||Use at an assay dependent dilution. PubMed: 21163944|
FunctionMay be involved in desquamation.
Tissue specificityExpressed in skin, breast, brain and testis. Expressed at the stratum granulosum of palmar skin.
Sequence similaritiesBelongs to the peptidase S1 family. Kallikrein subfamily.
Contains 1 peptidase S1 domain.
- Information by UniProt
- HK5 antibody
- Kallikrein 5 antibody
- Kallikrein L2 antibody
All lanes : Anti-Kallikrein 5 antibody - Kallikrein loop (ab28565) at 1/1000 dilution
Lane 1 : Kallikrein 5 at 0.05 µg
Lane 2 : Kallikrein 5 at 0.01 µg
Lane 3 : Kallikrein 5 at 0.001 µg
Predicted band size: 32 kDa
Observed band size: 38 kDa why is the actual band size different from the predicted?
This product has been referenced in:
- Jiang R et al. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem 286:9127-35 (2011). ICC/IF ; Human . Read more (PubMed: 21163944) »
- Ghosh S et al. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression. Mol Cancer Res 8:145-58 (2010). IHC-P ; Mouse . Read more (PubMed: 20145038) »